Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-NS001 versus Naprosyn in osteoarthritis: gastric ulcer endoscopy study
2009-018029-57Phase 2Completed
- Sponsor
- Logical Therapeutics
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naproxen etemesil in knee osteoarthritis (OA) (2 arms), sponsored by Logical Therapeutics. Primary endpoint: Primary GI safety endpoint. Started Mar 2010; status: completed.
02
Drugs
naproxen etemesil
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-018029-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018029-57.